












Center for Health Adminitstration
Snorre Kverndokk
Ragnar Frisch Centre for
Economic Research
Working Paper 2001: 7© 2001 HERO and the author – Reproduction is permitted when the source is referred to.
Financial support from
Th
Research Council of Norwayis acknowledged.
HealthEconomicsResearch programme at the University of Oslo 1998- 2003.
ISSN 1501-9071, ISBN 82-7756-069-9
On adaptation, life-extension possibilities







The purpose of this paper is to analyse the impacts of adaptation to a falling health
state on the demand for health and medical care. This is done by integrating
adaptation processes in the pure consumption model of Grossman.
We also modify the model in another direction by introducing an uncertain lifetime.
Model simulations show that adaptation affects the health variables by lowering the
incentives to invest in health, as well as smoothening the optimal health stock path
over the life cycle. Whether or not the risk of mortality is an object of choice has
important effects on the joint development of the health variables.
JEL classification: C61; D91; I12.
Keywords: Grossman model; Demand for health; Adaptation; Life extension; Ageing.
1 This paper is part of the HERO program at the University of Oslo, and is funded by the Norwegian
Research Council. We are indebted to discussions with Paul Dolan and Michael Hoel, to comments
from Tor Iversen and seminar participants in Oslo and Bø, and to Jared Carbone for research
assistance.
* Norwegian Computing Center, P.O. Box 114 Blindern, 0314 Oslo, Norway.
** Center for Health Administration, University of Oslo, The National Hospital, 0027
Oslo, Norway.






In standard neoclassical economics, the main carriers of utility or well-being are the 
absolute characteristics (or levels) of goods. However, some economic modelling 
deviates from this approach by introducing reference points in objective functions. 
This literature can be classified into two distinct groups. The first and most important 
approach is “status models” for which certain levels of variables of other individuals 
or groups constitute the reference points for the object of the study (external reference 
points). Analyses of this kind are found in Hirsch (1976), Frank (1985; 1989) and Ng 
and Wang (1993) as well as in the works of Veblen (1899), Duesenberry (1949) and 
Johansen (1961). The above studies focus on individual satisfaction being determined 
by relative standings in consumption and income, and introduce concepts like 
“conspicuous consumption”, “positional goods” or “demonstrative consumption”.
2 
 
A second group of models applies internal reference points for the individual being 
considered. Studies of this kind include works on habits and addiction for which 
(utility of) present consumption depends on the history of past consumption (see, e.g., 
Pollak, 1970; 1976, and Becker and Murphy, 1986), as well as aspiration models. 
Here, utility generated by a consumption bundle depends on the individual’s 
aspiration level represented by own expectations about future performance. Aspiration 
levels are often perceived as being endogenous, depending on factors such as past or 
current performance relative to actual performance (see Ng and Wang, 1993, for 
references). 
 
Yet another type of internal reference points is adaptation theory. The concept of 
adaptation originates from biology where it is used to describe adjustments to the 
conditions under which species must live in order to survive.
3 Adaptation processes 
are also discussed in economic literature on preference formation (see Ng and Wang 
1993; Rabin, 1998; Frank, 1989) as well as in studies on health status evaluation 
where they are used to describe the ability individuals have to cope or adapt to malign 
changes in health.
4 The theory postulates that humans are sensitive to context, frame, 
                                                 
2 See also Easterlin (1996) and Hellevik (1999) for survey evidence on this topic.  
3 See also work in psychology, e.g., Helson (1964). 
4 Adaptation is also related to changes in tastes, for instance tastes that are formed under conditions of 




or the current situation rather than absolute characteristics, only. In this perspective, 
adaptation suggests mechanisms different from those applied in traditional approaches 
on health demand such as the pioneering works of Grossman (1972a,b) and 
subsequent extensions (see, e.g., Muurinen, 1982; Wagstaff, 1986; Ehrlich and 
Chuma, 1990; Ried, 1998; Eisenring, 1999; Jacobson, 2000). Consequently, it would 
be of interest to investigate whether adaptation processes have implications for the 
results arrived in Grossman types of models, especially since some of their 
implications are contradicted by available evidence.
5 
 
In the Grossman model, health is considered a capital stock that increases due to 
investment (buying health services, medical goods, or spending time on healthy 
activities), and decreases in response to an advancing age. According to this model, 
there are three reasons why individuals demand health. First, health is a consumption 
commodity in the way that it directly enters the individual utility function. Good 
health implies higher utility than bad health for a given consumption level. The 
second reason to demand health is based on health as an investment commodity. 
Health determines the total amount of time available for market and non-market 
activities, e.g., bad health gives more sick days than good health. Available time 
increases in health, which again represents a monetary value. This may be thought of 
as a return to investment in health. The third reason follows from health determining 
the length of life. A good health condition may give a longer lifetime. Of the three 
reasons to demand health, adaptation will be important only for health as consumption 
good, i.e., how much the utility will be affected from changes in the objective health 
state. 
 
We do not know any other studies that formalise adaptation processes.
6 In this paper, 
therefore, an effort is made to integrate adaptation to ageing in a formal model 
framework. This means that instead of studying rapid changes in health due sickness 
or accidents, we concentrate on the natural decline in health, as one grows older, i.e., 
                                                                                                                                           
unemployed, the hopeless destitute” (see Sen, 1987, p.11). Thus, these processes are not always 
wanted. 
5 Zweifel and Breyer, 1997, provide an overview of some studies. The results are rather mixed. 
6 Kverndokk (2000) proposes several ways to extend the standard model for demand for health and 
medical care. Formal specifications of psychological aspects such as status seeking, identity seeking 




how we adapt to becoming old.
7 In order to keep the analysis tractable we restrict 
ourselves to the pure consumption model of Grossman (1972a,b).
8 The model is 
extended in yet another direction, by leaving the common assumption of a fixed 
lifetime or an endogenous lifetime being determined by the stock of health capital 
reaching a minimum level (see, e.g., Wolfe, 1985, Ehrlich and Chuma, 1990, Ried, 
1998, Eisenring, 1999 and Jacobson, 2000). Rather we prefer to introduce uncertainty 
into the model by modelling a probability of life-termination decreasing in the stock 
of health capital (i.e., the random date of death is conditioned upon objective health 
status). This allows us to split the demand for health in two parts, as a consumption 
commodity and as a mean to extend life. Only the first part is affected by adaptation. 
 
In the next section we define the concept of adaptation and discusses its relationship 
with ageing. In section 3 the theoretical model is presented. Section 4 describes the 
main results from numerical simulations of the model. In particular, we focus on the 
implications of the adaptation process for health demand including shifts in 
exogenous variables and model parameters. Section 5 concludes. 
 
2. ADAPTATION AND AGEING 
In the literature, adaptation processes are mainly discussed i) in the context of abrupt 
and unexpected changes in health conditions and ii) for individuals with handicaps 
and chronic illnesses. However, adaptation may also be relevant in the context of a 
gradually declining health due to an advancing age. The fact that health deteriorates 
with age is common knowledge and most likely people realise that their future 
evaluations of health will be conditioned on age itself. In this perspective it seems 
adequate to integrate adaptation in a health planning perspective. 
                                                 
7 In the Grossman model, utility is increasing in consumption and health, where consumption is viewed 
as an aggregate of all commodities besides health that enter the utility function including leisure time. 
Thus, if the health stock falls over time due to ageing, the way to maintain the utility level is to increase 
material consumption or leisure time. While leisure time increases when people retire, data for the UK 
and the US suggest that both consumption and income has a hump-shaped profile, with a peak around 
age 45 (see Attanasio and Banks, 1998). The effect on utility may, therefore, be ambiguous. However 
one indication is found in a Norwegian survey on self-reported happiness (Hellevik, 1999), where good 
health is found to be one of the main determinants. The study reports a falling level of happiness with 
age, from a top at around age 25-35. According to the study, reasons for lower level of happiness 
among elderly people may be a lower health state as well as loneliness. Adaptation will reduce the 





According to Heyink (1993, p. 1332), adaptation may be defined as “an intrapsychic 
process in which past, present, and future situations are circumstances given such 
cognitive and emotional meaning that an acceptable level of well-being is achieved”. 
Mentzel et al., (1999) perceive adaptation as the alteration of activities, desires, goals, 
and values in response to changes in health states and suggest six different factors all 
considered to be potential elements of adaptation. These are; skill enhancement, 
activity adjustment, substantive goal adjustment, lowered expectations, heightened 
stoicism and altered conception of health. The same study distinguishes adaptation 
processes both from initial shocks related to health state changes and the increased 
knowledge that arises from experiencing adverse health conditions. 
 
There is some empirical evidence supporting adaptation processes when health 
deteriorates naturally over time.
9 In health surveys for Norway conducted by Statistics 
Norway, see SSB (1999), elderly people in general consider their health as good, even 
if many of them reported serious or less serious illnesses or worries. For people above 
age 80, 20 per cent reported bad health. This is a bit surprising as 27 per cent of the 
respondents above age 80 reported that they had an illness that strongly affected their 
everyday life. SSB suggests that the reason may be that health expectations are 
reduced when one live as long as 80 years or more. Cassilleth et al., (1984) found, in a 
study examining 758 patients, that older people seem to develop more effective skills 
with which to manage stressful life events. ”There may be a biological, evolutionary 
advantage for older patients, enabling them to adapt to illnesses that are 
epidemiologically associated with advancing years” (p. 509). Van Maanen (1988) 
reports studies among self-defined healthy American born elderly and ill-healthy 
British born older persons. The results indicate that many dimensions other than the 
absence of disease and illnesses determine the perception of health. The older the 
person, the more emphasis was placed on health as a state of mind, even in situations 
of a gradually falling body. Groot (2000) found elderly people to report better health 
                                                                                                                                           
8 Analysing adaptation in relation to health as an investment good seems less relevant since income 
tends to be a function of objective health rather than subjective health evaluations. 
9 Empirically, it may be difficult to distinguish between adaptation and comparisons to reference 
groups, as both effects may give the same result (see Groot, 2000). With external reference points, 




than younger people. One reason may be that elderly people may be more adaptive 
than younger people: “Older people may have become more accustomed and have had 
more time to adapt to their health impairments” (p. 413). 
 
Findings from studies on adaptation have also triggered a debate on whom to ask 
about the utility of health states (patients, health personnel, or the general public) and 
whether patients, if asked, should report ex-ante or ex-post utilities.
10 E.g., Adang 
(1997) found that that people who have been through successful transplants assess 
their pre-transplant quality of life lower relative to assessments made before the 
transplants took place. Also, Sackett and Torrance (1978) found that patients rated the 
value of an impaired state of health more highly than the general public, suggesting 
that people with deteriorating health adapt to their health condition over time. 
 
This evidence suggests that people may adapt to a lower health level over time. One 
implication is that even if one believes that the adaptive behaviour should not be taken 
into account in health policies such as allocating scarce resources, adaptation may be 
important in explaining behaviour, such as the demand for medical care. We, 
therefore, include an adaptive health measure in a theoretical and numerical analysis 
explaining individual behaviour. 
 
3. THE MODEL 
In this section we present a theoretical model, which is based on the pure 
consumption model of Grossman but modified in two respects. First, adaptation 
processes are introduced, and second, we apply a probabilistic approach to life 
termination (uncertain lifetime). 
3.1 The adaptation process 
The utility of an individual at any point of time, t, is represented by the following 
function: 
                                                                                                                                           
points, they compare with themselves, e.g., their own health in earlier periods of time. The latter means 
that they may adapt to a certain health state. 
10 Cost-utility and cost-effectiveness analysis are methods designed to help decision-makers in the 
health sector to distribute scarce resources to where they yield the greatest benefits. Such methods 7
(1) Ut =U ( C t,K t)
C denotes consumption of goods and K is a health-related variable for which utility
assessments are being made (subjective health). The utility function is strictly concave
in C and K.
10 The specification of the adaptive processes is inspired by Hoel and
Isaksen (1994);
11
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where H denotes the objective health state. From (2) it follows that subjective health,
K, at date t becomes a function of the initial health endowment, H0 > 0, and a
weighted sum of all past changes in (objective) health states,H ! . Thus, a dot over a
variable represents its derivative with respect to time. The non-negative parameter β
determines the “weight”, and represents the degree of adaptation for which the rate
rather than the state of health becomes important for well-being. The development in
K over time follows the differential equation in (3):








Considering two special cases, β→ ∞and β = 0. From (2) we find:
require an estimate of health states. One methodology for estimating societal value of healthy
interventions suggests the use of individual utilities.
10 Our model can be considered a variant of the theory of tastes as presented in Becker (1996).
Equation (1) represents an extended utility function, which is a stable function over time of the goods
consumed and also of the health related capital stock. If an unexpected event that reduces the future
objective health stock happens, the utility function will not change but there will be a change in the
utility level. However, the subutility function that depends only on goods is unstable, as it will shift
dependent on the level of the health related capital stock. In this case, the preferences for goods become
endogenous, determined by the individual’s health history, so that the individual rank consumption
goods differently after experienced a change in health.
11 Hoel and Isaksen (1994) apply a related specification when introducing global temperature changes
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Thus, if β = 0, there is no adaptation. Subjective health coincides with objective 
health and the utility function in (1) becomes equal to those applied in human capital 
models in the health literature. For β → ∞, however, subjective health equals the 
current change in the objective health state only. This can be denoted “perfect 
adaptation” since the individual is indifferent to absolute levels of objective health but 
responds only to the most recent change in the health state. He suffers a loss only in 
the period when the health is deteriorated, and will adapt perfectly to this change from 
the next period onwards. For all other cases, i.e., 0 < β < ∞, past changes in health 
states count less than current changes. If, e.g., β = 0.05, a current change in health is 
e
20β = e =2.71828 times as important as a similar change in health 20 years ago.  
 
Figure 1 illustrates the adaptation processes for the three cases above, with an abrupt 
change in health. Assume that the consumption level is constant and also that health 
state is constant at Ht = H1 for an interval of time, t < t1. Thus, in this time period, 
utility is constant for all possible values of β.
13 At t1 a sudden negative change in 
health occurs, and the health state will remain at a lower level, Ht = H2 < H1, for t ≥ t1. 
This reduction in H will cause an immediate downward shift in both K and utility, 
however the development in these variables depends on the value of β. For β = 0, K = 
H and utility will remain constant at a lower level, see panel a). If β → ∞, the 
individual will suffer a loss only at time t1 as shown in panel b). Finally, for 0 < β < 
∞, the individual will suffer an initial loss at t = t1, but for later periods, K will 
steadily increase over time and approach its initial value. Utility will, therefore, also 
approach its previous level. Thus, this particular shift in health state becomes less 
decisive for the evaluations of health, the longer the distance in time, see panel c). 
                                                 
13 Note that the initial utility and also the drop in the utility will be different for the three different cases 
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FIGURE 1:  Adaptation processes for different values of β. 




Our formulation in (2) seem to capture one essential feature of health adaptation 
processes being discussed in the literature, namely that a given level of health does 
not produce the same level of utility irrespective of the context in which it occurs. 
Changes in health states become decisive for health evaluations, introducing a 
sequence of internal reference points. 
 
3.2 The uncertain lifetime 
The lifetime of the individual is not known in the model. Rather, we assume that good 
health reduces the possibility of an early life termination, i.e., the higher the objective 
health state is, the lower is the probability of death defined by a utility equal to zero in 
all future periods. This introduces stochastic in the model. The individual is not able 
to determine the length of life, but can attach subjective probabilities to the 
occurrence of death, which are not revised over time. The probabilities depend on the 
objective health states. Thus, even if the individual is able to adapt to reduced health 
over time, he is aware of the objective health situation: An old person who has 
adapted to the health effects of ageing, knows that his objective health is not as good 
as it used to be, and, therefore, that the probability of dying is higher than before. As a 
consequence, the probabilities of dying are endogenous. For similar approaches to a 
random lifetime, see Cropper (1977) and Ehrlich (2000). 
 
The individual’s beliefs about a catastrophic event such as death at an arbitrarily 
instant of time is represented by a hazard function, which is the change in the 
probability of death to occur in the time interval (t, t+ε) given that death has not 
occurred at earlier instants of time (see, e.g., Kiefer, 1988, and Gjerde et al., 1999, for 
an application to climate catastrophes). The hazard function,  y  , is related to the 
objective health state in the following way; 
 
(6)  ) ( t t H h y =   
 
where a higher health state means that the beliefs about the occurrence of a 
catastrophe, will undergo a negative shift. We assume that h’ < 0 and h’’ > 0, i.e., a 




stock is high, but has a high impact when the health stock is low. Furthermore, a 
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The survivor function evaluated at time t is dependent on all hazard functions from 
the initial planning date and until t, and can be defined as the probability of 
experiencing no catastrophe by date t seen from the initial date.  
 
Using (7), we can express the discounted expected lifetime utility of the individual, 
LU, where ρ is the time preference rate, and the utility at death is zero:
14 
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3.3 Investments in health 
Due to the benefits of a high health state, the individual has an incentive to increase 
the stock of health by buying medical care,
15 I ≥ 0. However, the health stock will 
depreciate due to ageing, with the depreciation rate set equal to δt, and 
0 / > ∂ ∂ = t t t δ δ  for all t. This is a necessary condition for H to be a falling function 
of time at least after a certain age, see, Grossman (1972) and Ehrlich and Chuma 
(1990). 
 
(9) t t t t H I F H δ − = ) (   
 
The F-function, which represents health investments, is concave in I, reflecting that 
there are diminishing returns from buying medical care at a given point of time. 
                                                 
14 LU represents the discounted expected utility over an infinite period of time. However, as the risk of 
dying is increasing with lower health, the possibility of living over an infinite period of time can be 
ignored. Alternatively, the planning horizon can be set equal to D, where D is the maximum possible 
life length, see also the discussion in Ehrlich (2000). 
15 In the following, medical care is used as a proxy for all services and goods that can be bought to 





3.4 The budget constraint 
The individual’s budget constraint is given by the following equation; 
 
(10)  t t t t t t t C p I q Y rA A − − + =   
 
where A is wealth, r is the market interest rate, Y is income, and q and p are prices of 
medical care and consumption respectively. Thus, in this model, income is 
independent of health. We restrict the wealth to be non-negative in all periods, i.e., 
0 ≥ t A .
16 
 
3.5 Solving the model 
The forward-looking individual determines C and I in all periods by maximising 
expected lifetime utility, given by (8), subject to the development in the state 
variables K, y, H and A (see (3), (6), (9) and (10)), and the restrictions on H0 and At. 
The introduction of the hazard function has enabled us to solve the stochastic 
maximisation problem by using deterministic control, and the current value 
Hamiltonian function, V, for this problem is;  
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where λ, γ, µ, and η are current value shadow prices for objective health, death, money 
and subjective health, respectively. Since the Hamiltonian is strictly concave in C and 
I, the sufficient conditions assuming interior optimal solutions become (Seierstad and 
Sydsæter, 1987);  
 
                                                 
16 A similar restriction is used in Ehrlich (2000). In deterministic models such as in Ehrlich and Chuma 
(1990), A(T) ≥ 0, where T is the finite terminal period, is used. This allows for negative wealth in 
certain periods. However, as the time of death is stochastic, At ≥ 0 is introduced to avoid that the 
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with the following transversality conditions: 
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The flow conditions for optimal consumption and optimal medical care use presented 
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The expectation operator, E, in (22) and (23) is taken with respect to the random 
variable τ  being the time of death. 
 
From (19) it follows that along the optimal consumption path the price of the 
consumption good is equal to the money equivalent of the expected marginal utility of 
consumption. The expression for the optimal path of medical care in (20) is somewhat 
more complex. Here, the unit price of medical care is to equal the money equivalent 
of the expected net gains arising from buying an additional unit of medical care. It 
follows that net gains are determined by the shadow price of objective health,  t λ , and 
the shadow price of subjective health,  t η . 
 
From (21), we see that µt > 0, for t < ∞, i.e., the shadow price of money is positive and 
represents the additional utility benefit of an increase in A. It is decreasing over time 
for r > ρ. The shadow price of a death, γ, is the discounted expected utility measured 
in negative value, i.e., it represents the loss to the individual if he dies in period t. 
Thus, γt < 0, for t < ∞, see (22). We see from (23) that the shadow price of the 
subjective health stock, η, represents the discounted expected utility of an increase in 
K. As utility is increasing in K, ηt > 0 for t < ∞. The shadow price of the objective 
health stock, which is the expected utility effects of a current increase in H, 
discounted by the time preference rate as well as the depreciation rate, is determined 
by several effects, see (24). The first term within the parentheses represents the 
positive value an increase in H has on life extension. Further, a higher health stock 
has an impact on the subjective stock of health, which again has implications for 
utility. However, it will also involve costs in terms of additional future health 
depreciation (see 9). The two last effects are given by the second term within the 















where g is the unit value of health capital. Using equations (14) and (16), we can 
derive the stock condition for the optimal level of health stock (see also Erlich and 
Chuma, 1990): 
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The left-hand side of equation (26) is the instantaneous user cost of health capital, 
which has a similar form as the user cost of capital from investment theory. Thus, the 
user cost should equal the instantaneous marginal benefit of increasing the health 
stock with one unit. The latter term is the expected utility effects of an increase in the 
health stock, and consists of the same three effects as the shadow price of objective 
health, see above. The left hand side is also called the “marginal efficiency of capital” 
(MEC), see, e.g., Grossman (1972a). 
 
As an illustration of the effects of adaptation, consider the stock conditions for the 
special cases, β = 0 and β = ∞. For β = 0, K = H, and there is no adaptation. Equation 




t t H t t
t t
t












For this case MEC is always positive, as an increase in health extends expected 
lifetime as well as the life quality. However for β = ∞,  H K  = , and the individual is a 
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As before, an increase in health increases expected lifetime, and the first term in the 
parentheses is positive. However, the second term is negative: a higher stock of health 
means a higher depreciation and thus a higher fall in future health. Therefore, for the 
perfect adapter, MEC may be positive or negative depending on which effect is the 
largest. 
 
4. NUMERICAL RESULTS 
There are several difficulties in characterising optimal paths and conducting 
comparative dynamics in a continuous time model with four stock variables (see also 
paragraph 4.3 below). For this reason we apply a numerical version of the model to 
explore the impacts of adaptation on health stock and medical care. 
  
The model specification and parameter values are given in Appendix 1. Some 
important assumptions are, however; (i) an additive utility function in consumption 
and health, and (ii) a Weibull distribution to characterize the hazard rate function. The 
calibration of the benchmark scenario with no adaptation (GMEN, Grossman Model 
ENdogenous hazard) was conducted in order to reach realistic age profiles for the 
health variables, consumption, as well as for the contingent probabilities for the 
occurrence of death. Health stock and consumption paths are calibrated to reach their 
maximal values at young ages (30) and the mid-phase of life (50), respectively. The 
first is an assumption, while the second is based on empirical evidence from the US 
and the UK (Attanasio and Banks, 1998), see also footnote 7. To reach a realistic 
development in the contingent probabilities for the occurrence of death, we calibrated 
the model to reproduce a realistic expected length of life estimate for an individual 
living in an industrialised country; see, e.g., SSB (2000). 
 
The model is optimised for a horizon of 140 years, using 10-year periods, however, 
we restrict our graphical presentations to the first 100 years only. Simulations were 
carried out using the GAMS/MINOS system (Brooke et al. 1992), and the GAMS 





4.1 THE ROLE OF HAZARD FUNCTIONS 
Modelling life-termination as a stochastic decision (hazard function approach) 
represents an improvement to former approaches. For this reason, we start with 
simulations showing the role of mortality-risk being an object of choice. Figure 2 
describes the optimal health stock paths in our version of the pure consumption model 
of Grossman (β = 0) for two different assumptions. The dotted line represents the 
model with the hazard rate being a decreasing function in health (GMEN), while the 
straight line represents a model where the hazard function is exogenous (GMEX, 
Grossman Model EXogenous hazard). This scenario is designed by feeding the hazard 
probabilities, determined in GMEN, exogenously into the model and then re-
optimising. In this way we end up with a model where health still affects the quality 
of life, but without any possibilities to demand expected life-extension (quantity of 
life). By comparing model runs in GMEX and GMEN, we derive information on the 


















Figure 2: Optimal health stock paths for the pure Grossman consumption model  
















The two paths presented in Figure 2 envisage similar shapes, but GMEX yields lower 
health stocks at any date compared to GMEN. This is as expected since an exogenous 
hazard rate means lower returns to health investments relative to a situation where 
investing in expected life-extension is an option, se equation (26). The optimal stock 
of health increases gradually in the first phase of life for then to decrease as the 
individual becomes older (inverted U). This finding is inconsistent with some 
conclusions in the literature on the pure consumption model of Grossman, where a 
unique negative relationship between age and health is identified (see Zweifel and 
Breyer, 1997, and the references therein). However, we can quite easily identify a 
monotone declining relationship between age and health stock in the numerical model 
by, e.g., assuming a sufficiently high initial endowment of health.
17 Thus, our model 
allows for several possibilities as concerns the optimal health stock path, but a 
converted U seems realistic.
18 A similar result is found in Grossman (1972b), where 
health stock, in the first phase of life, is found to increase with age for a positive 
interest rate (r) and a health depreciation effect that increases with age. 
 
In Figure 3, the developments in the use of medical care (I) for the two models are 
presented. Surprisingly, the two paths turn out very differently. For GMEN, the use of 
medical care is more or less stable (initial decline) the first decades, then rapidly 
increasing, and finally undergoing a sharp decline in the last phase of life (inverted 
U). The top is at 60 years. The reason why the use of medical care is falling at high 
ages, is that the individual does not expect to live that long - the expected lifetime in 
GMEN is 73.9 years
19 - and he prefers to spend the money on consumption at earlier 
stages of life instead. In GMEX, on the other hand, the path is gradually declining 
throughout life. Hence, choosing an exogenous rather than an endogenous hazard 
function is important for the shape of the path for medical care. We observe, as 
expected, that the use of medical care are significantly lower at all ages in GMEX 
                                                 
17 For GMEN, a negative relationship is achieved by increasing H0 by 300%. 
18 One indication of an increasing health in the first stage of life is a falling death rate (see, e.g., SSB, 
2000, for Norwegian data). 
19 This is subject to that the individual dies before he turns 110. If the individual can live for 140 years, 
the expected lifetime is 79.5 years. In comparison, the expected lifetime for men in Denmark (1997) 
was 73.3 years; while it was 74.6 in France (1999), see SSB (2000). In the following we will only 




compared to GMEN. At age 20 the reduction is about 75% and at age 60 the decrease 

















Figure 3. Optimal paths for medical care in the pure Grossman consumption model 
(β = 0) with endogenous and exogenous hazard functions.  
 
The possibility to demand (expected) longevity does not only raise health investments 
but also affects the distribution of buying medical care over time by concentrating it 
to the mid-phase of life. Hence, considering health as a means of life-extension and 
not only as life-quality provider is important. In spite of the very different shapes of 
the two paths, both exhibit developments that are different from findings presented in 
Zweifel and Breyer (1997), where a positive theoretical relationship is identified 
between age and health investments. As this cannot be a general result,
20 it is of some 
                                                 
20 As there is a positive transformation from medical care to health investments in our model, the 






















. Thus, health investments are falling if the term in the parenthesis on the 
right hand side is negative, and increasing if it is positive. While δ  is always positive, first and second 
order derivatives of the health stock vary over time, and health investments may fall or rise when the 

















interest since many implications of the Grossman model (consumption model as well 
as the investment model) are being contradicted by available empirical evidence (see 
Zweifel and Breyer, 1997, for an overview). 
 
4.2 THE ROLE OF ADAPTATION 
We now turn to the impact adaptation processes may have for health-related decision-
making. The model with an endogenous hazard function is considered for three 
different values of β; β = 0 (no adaptation), β = 1 (some adaptation) and β = ∞ 
(perfect adaptation). From Figure 4 it follows that adaptation has a modest impact on 
the optimal stock of health compared to the effects of different hazard functions (see 
Figure 2). Parts of the explanation lie of course with the fact that health investments 
are heavily motivated by life-extension motives which are not subject to adaptive 
processes. However, it turns out that the impact on the health stock from adaptation is 
relative modest also when compared to the effects arising from shifts in exogenous 
variables of the model, see paragraph 4.3 below. Furthermore, an increasing degree of 
adaptation (a higherβ ), yields the most significant downward shift (in both absolute 
and relative terms) in the mid-phase of life, while the optimal health path is almost 
catching up again late in life. With adaptation, the expected lifetime falls from 73.9 (β 




















Figure 4. Optimal health stock paths for varying degrees of adaptation (β = 0;  
β = 1; β = ∞) in a model with an endogenous hazard function.  
 
Figure 5 presents the effects on medical care use from an increasing degree of 
adaptation. Also for this variable, the magnitude of the shift differs somewhat over 
time. In both relative and absolute terms, the shifts are most significant in the first and 
mid-phase of life, while they become weak and almost insignificant at an advancing 
age. With perfect adaptation, the use of medical care decline roughly by 30% in the 
first phase of life, and by about 10-15 % in the mid-phase. The reductions observed in 
medical care and health stock over time make evident that adaptation, as formulated 
in this paper, lowers the incentives for investing in health. This effect is not surprising 



































Figure 5: Optimal paths for medical care for varying degrees of adaptation (β = 0; 
β = 1; β = ∞) in a model with an endogenous hazard function.  
 
The fact that the magnitude of shifts changes over the planning horizon in response to 
adaptation for both health variables deserves more attention. We already know from 
Figures 4 and 5 that path deviations appear almost insignificant late in life (in absolute 
terms) compared to the pure Grossman consumption model (GMEN). For the stock of 
health, the most significant downward shifts occur in the mid-phase of life, while for 
medical care the shifts are most significant in the first phase of life (30% at age 20 
and 10% at age 60 for β → ∞). These findings are somewhat different from those 
arrived at when comparing the same two variables in Figures 2 and 3. Here, the 
differences in health stock are found to increase steadily over time, both in absolute 
and relative terms. For medical care, the gap between GMEX and GMEN increases 
rapidly until age 70, for then to be reduced. Thus, a decline in returns to health 
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Adaptation processes as well as the absence of possibilities to demand (expected) life-
extension make health and hence health investments less attractive, however their 
impact on health decision-making differ. The presence of adaptation triggers 
behaviour that smoothens the optimal health stock path over time, i.e., the path 
becomes flatter. This effect is best illustrated by the case of perfect adaptation (β = 
∞), for which the immediate health stock change is the only health-related argument 
in the utility function. The build-up of health at early dates involves costs later in life, 
since future falls in the stock due to increased depreciation are unavoidable. This 
effect, ceteris paribus, gives a smoothening incentive for the development of the 
health stock over time. The optimal consumption path shifts upwards in response to 
adaptation for the first 60 years, suggesting that adaptation makes health less 
attractive relative to consumption. However, the peak identified at age 50 in the 


















Figure 6: Optimal health stock paths for varying degrees of adaptation (β = 0; β = 1; 
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Figure 6 also sheds light on the role of adaptation processes, but now for the model 
with an exogenous hazard function. Adaptation has much the same impacts as the 
ones identified for an endogenous hazard function. As before, a higher degree of 
adaptation causes a downward shift in the stock of health over time, and the 
magnitude of the shift, in absolute terms, gradually increases in the first phase of life, 
for then to become smaller at later dates. Late in life, the paths almost converge. 
However, the presence of adaptation processes has a more significant effect on health 
compared to the case with an endogenous hazard function. This finding is self-evident 


















Figure 7: Optimal paths for medical care for varying degrees of adaptation (β = 0; 
β = 1; β = ∞) in a model with an exogenous hazard function. 
 
The optimal paths for medical care are presented in Figure 7. We already know from 
Figure 3, that the path in GMEX exhibits a development different from the one in 
GMEN. However, as seen from Figure 7, this fact does not change the impact from 
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and the shifts are, both in absolute and relative terms, very significant early in life 
(60% at age 20 and 50% at age 60 for β → ∞) while they become relatively weaker at 
the end of the life cycle. However, adaptive medical care paths are not necessarily 
steadily declining over time, as was the case for β = 0 in Figure 7. The smoothening 
of the paths for medical care identified seems to follow from the need to smoothen 
optimal health stock paths in response to adaptation. 
 
To sum up, we have identified two effects arising from adaptation. First, adaptation 
lowers the rate of return to health investments yielding both lower use of medical care 
and lower stocks of health at any date throughout the planning horizon. Second, 
adaptation represents an incentive to smoothen health stock paths. For the model 
version with an exogenous hazard function, such a change of behaviour induces a 
smoothening of the medical care path as well, while for the model version with an 
endogenous hazard this is not the case. The above discussions have also shown that 
the assumptions made about life-termination have important implications for health-
related decision-making. 
 
4.3 COMPARATIVE DYNAMICS 
There is a debate in the literature on the proper methodology to conduct comparative 
dynamics in models with several stock variables (see, e.g., the discussions in Ehrlich 
and Chuma, 1990; Ried, 1998; Eisenberg, 1999).
21 This fact, together with 
modifications of the basic model of Grossman, makes it somewhat confusing to 
review and compare the theoretical predictions arrived at across studies. 
 
In the following we present the behavioural implications concerning the effects of 
exogenous variables in our model (comparative dynamics). The effects on optimal 
paths over the life cycle are derived from numerical simulations. In Table 1 we only 
                                                 
21 Ehrlich and Chuma (1990) challenge some of the methodology applied by Grossman (as well as 
subsequent works see Muurinen, 1982; Wolfe, 1985 and Cropper, 1977) with respect to model 
specification (linear Hamiltonian) and the transversality conditions applied. See also Grossman (1998). 
Eisenberg (1999) and Ried (1998) do not find Ehrlich and Chuma’s application of Oniki’s (1973) path 
analysis satisfactory for problems with more than one stock variable. Ried (1998), which appear to 
represent the most satisfactory approach, applies Frisch decision functions in a discrete version of the 
full Grossman model to undertake comparative dynamics. Here, the direction of most effects analysed 




present the results from our version of the pure Grossman consumption model 
(GMEN), since comparative dynamics in the model versions with adaptation did not 
give significant differences relative to GMEN, with the exception of shifts being 
slightly weaker, in particular for consumption and medical care paths. 
 
As follows from Table 1, higher initial wealth (A0) yields a unique positive shift for 
the optimal paths of health stock, medical care, as well as consumption. Furthermore 
it is seen that the probability of life-termination, undergoes a unique downward shift. 
The conclusions coincide with the ones derived for a higher exogenous income at all 
dates (Y). However, a higher income from 70 years onwards (2/3 of previous 
income), did not change results much as the expectations of living are low. These 
results are all more or less as expected, in that additional financial resources increase 
both the demand for consumption and health. However, this is different from the 
conclusions reported in Zweifel and Breyer (1997) on the pure Grossman 




Table 1: Comparative dynamics predictions (GMEN). 
                                             Exogenous variables
a 
A0  H0  Y   q   ρ r δ
 
+  + + ÷  ÷  ÷/+  ÷ 
+  ÷/+ +  ÷  ÷  ÷/+ +/ ÷ 







b  ÷  ÷  ÷  + +  +/ ÷ + 
Note: The signs and their sequence describe the direction of the shifts in paths for the respective 
endogenous variable. (+) implies an increase in the endogenous variable for all t, while ( ÷ /+) means a 
phase with lower values first and a later phase with higher values. 
a A0 is increased by 100%, q by 50%, and Y by 20% (100% late in life) compared to the benchmark 
scenario (GMEN). H0 increases with 50%, ρ increases from 3% to 4%, r from 4% to 5%, while δ 
increases with one additional percentage point throughout the horizon of the model as compared to 
GMEN.  
b (1-e
-y(t)) is the probability of life-termination until date t seen from the initial date, i.e., a negative shift 
means a higher expected lifetime.  
 
                                                 
22 This conclusion is somewhat surprising in view of theoretical modelling being more general 




A higher unit price on medical care (q) and a higher time preference rate (ρ) induce 
the same direction of shifts. Health investments are lower at all dates, consequently 
the health stock becomes lower, the probability for life termination becomes higher, 
while optimal levels of consumption are higher in early years but lower at older ages. 
A higher time preference rate is expected to increase the demand for consumption at 
early dates at the expense of the same demand later in life as well as for health. This is 
confirmed, however, the negative impact on medical care use early in life is quite 
weak but increases rapidly over time. Later in life, however, the gap narrows, most 
probably it can be attributed to the strong impact demand for longevity has in our 
numerical model. Grossman (1972b) finds that a lower time preference rate will 
prolong the initial time interval, for which health is increasing, however, the specific 




For a higher q the downward shift in medical care use is stable during the first and 
mid-phase of life, an observation being consistent with substitution of health with 
consumption in these periods of life. However, consumption is lower late in life, most 
probably being a result of the priority given to health investments in postponing death. 
A rather interesting observation is that adaptation induces shifts being similar to the 
ones derived for q and ρ. All induce lower medical care use over time, while 
consumption increases somewhat relative to the baseline scenario the first decades for 
then to become lower from mid-life and onwards. However, the convergence in the 
health stock path at old ages observed in models with adaptation is absent for shifts in 
q and ρ. 
 
A higher market interest rate (r) has more complex effects on the time profile of the 
endogenous variables. The paths for medical care and consumption are lower at early 
dates since returns to saving have increased, while additional financial resources 
available in the future increase both health and consumption at later dates. The same 
matters for medical care and consumption paths when an increase in the initial 
                                                 
23 A time preference rate of 3% may be high, but it turns out that this rate is crucial for determining the 
optimal consumption path. We calibrated the model for a consumption peak at around 50 year based on 
Attanasio and Banks (1998). With a lower time preference rate, the peak of the consumption path will 




endowment of health (H0) is undertaken, while the exact opposite relationship is 
observed for an (continuous) increase in the health depreciation rate (δ). As concerns 
a higher H0, marginal returns to health investments become lower. In order to keep 
health investment and thus the health stock relatively high from mid-life onwards, it 
becomes optimal to intensify saving early in life rather than to consume more. A 
higher rate of health depreciation (δ) skews medical care in favour of early health 
investments at the expense of late investments. However, the increase in medical care 
that takes place in the first period of life is not sufficiently strong to prevent the health 
stock itself from becoming lower in the first phase of life. A rather interesting 
observation is that the shifts induced by higher health depreciation rates are similar to 
the shifts induced by adaptation. The downward shift in health stock is most 
significant, absolute and relative, in mid-life, while late in life it tends to catch up with 
the optimal health stock path for lower depreciation rates. In this perspective, higher 
health depreciation rates also induce a smoothening of the optimal health stock path. 
 
4.4 SENSITIVITY ANALYSES 
As the parameterisation of the model is subject to discussion, sensitivity analyses are 
needed. Therefore, we made sensitivity analyses on the utility function, the 
investment function, and the hazard function. 
 
Increasing the weight on consumption on the expense of health in the utility function, 
gives negligible impacts of adaptation, while the opposite is the case for an increased 
weight on health. In the latter case, we get quite high positive impacts on medical care 
use, a lower consumption path (peak at 60 years) and a lower death probability. 
 
We assume a constant productivity of medical care in the health production function. 
Decreasing the productivity over time, i.e., as the individual gets older, gives 
negligible impacts on the health stock and the consumption path, but the path of 
medical care use will shift somewhat to the left, and the expected lifetime will slightly 
fall. Increasing the overall productivity by increasing the exponent in the investment 
function (as well as adjusting the hazard function to get a reasonable development of 
the death probability), gives high effects of adaptation. The health stock and medical 





Changes in the hazard function to increase the probability of dying, gives different 
changes in the paths dependent on which parameter is changed. But overall, the 
results do not provide much new information. 
  
To sum up, model runs show that the impact from adaptation increases for higher 
returns to medical care, by improving the weight of (subjective) health at the expense 




Our analysis links adaptation to ageing in the pure consumption model of Grossman 
with stochastic life-termination. We show that adaptation has two effects on health 
demand. First, the awareness of adaptation makes health investments less attractive, 
thus yielding a lower optimal health stock over time. Second, the same awareness 
gives an incentive for the individual to smoothen planned health stock paths. The 
effects of adaptation may, however, not be very high, as a main incentive for 
demanding health seems to be to prolong life. Furthermore, it follows that adaptation 
has effects on health, health investments, and consumption paths being similar to the 
effects that follow from a higher price on medical care and a higher time preference 
rate. However, the smoothening effect observed when analysing adaptation is absent 
for the same two variables, but show up for a shift in the health depreciation rate.  
 
There is a discussion in the literature of the proper way of doing comparative 
dynamics in models with many stock variables. We have, therefore, conducted the 
analysis on a numerical model, and we show that the effects that arise for the joint 
development in health and health investments when undertaking comparative 
dynamics are not changing across models ignoring adaptation and those that do not.  
 
As this analysis concentrates on the effect of adaptation on ageing, i.e., a continuous 
fall in health, several other interesting problems connected to adaptation is connected 




capture all aspects of the phenomena as described in the literature. There is a lack of 
formal analyses on adaptation, and future work may provide additional insight. 
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APPENDIX 1: Specifications and parameter values in the numerical model 
 
The utility function is additive in consumption and health stock:  
 
(, )( ) ( ) tt t t c t K UCK C L K L
αη =+ ++        ( A . 1 )  
 
LC and LK are set equal to 100, and are included to allow for a negative K-value and to 
balance C and K. α = 0.4 and η = 0.6. 
 





























y           ( A . 2 )  
 
ε = 2.5, while θ = 0.02 and ω = 37 are calibrated to arrive at adequate death 
probabilities over the life horizon. 
 
The health investment function is of the following type; 
 
γ
t t dI I F = ) (           ( A . 3 )  
 
where d is a constant equal to 1, while the power, γ, equals 0.1.  
 
Initial endowments of health, H0, and wealth, A0, are 50 and 250, respectively. The 
market interest rate, r, is set at 4% p.a., the utility discount factor, ρ, is assumed to be 
3%, while the unit prices of consumption (q) and medical care (p) are constant and 
equal to 1 in all periods. Annual income is 250 for the first 60 years, and 50 thereafter. 
The health depreciation rate, δ, varies over time and equals 1% the two first decades, 




APPENDIX 2: The GAMS code 
 
 




$setglobal betainf no 
$setglobal endog 1 
 
SET 
    T  time periods   /0, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140/; 
 
PARAMETERS 
   delta(T)  depreciation rate 
   q(T)    price on medical care 
   p(T)    price on consumption goods 
   Y(T)   income 
   EX_H(T)  Health stock path for exogenous probability runs  ; 
 
   delta(T) = (0.01$(ORD(T) LE 2) + 0.01*(ORD(T)-1)$(ORD(T) GT 2)); 
   q(T) = 1; 
   p(T) = 1; 
   Y(t) = 250; 
   EX_H(T) = 0; 
    
* Change income path to reflect retirement (lower income after age 70) 
 
   Y(t)$(ord(t) gt 7) = 50; 
   Y(t)$(ord(t) eq card(t)) = 0; 
 
SCALARS 
      H0   initial  health  stock     /  50  / 
      A0   initial  wealth      /  250  / 
   alpha    parameter in utility function (consumption)  / 0.4 / 
   beta    parameter in utility function (health)   / 0.6 /  
   kbeta    parameter in adaptation function    / 0 /  
   gamma  parameter in health production function   / 0.1 /  
   rate    market interest rate        / 0.04 / 
   pref    time preference rate        / 0.03 / 
   PAR1  parameter in hazard function     / 0.02 / 
   PAR2  parameter in hazard function     / 2.5 / 
   critical  parameter in hazard function     / 37 / 
   haz    endogenous probability flag      / 1 / 
   betainf  limiting adaptation case flag      / 0 / 
   lifetime1   expected lifetime                             / 0 / 








   K(T)   adaptation function 
   H_D(T)  change in health stock ; 
 
POSITIVE VARIABLES 
   C(T)   consumption 
   I(T)    medical care 
   H(T)   health stock 
   A(T)   wealth 
   LY(T)  integral of the hazard rate  
   KUM(T)  probability of dying ; 
 
FREE VARIABLES 
   UTIL    utility; 
 
EQUATIONS 
   UTILITY    intertemporal utility function 
   H_FUNC(T)   health definition 
   H_D_FUNC(T)  health transition 
   A_FUNC(T)   wealth definition 
   BUDGET(T)  period budget constraint 
   K_FUNC(T)   adapted health good definition 
   K_FUNC2(T)  adapted health good definition when kbeta is equal to infinity 
   AHAZARD(T)  endogenous hazard function 
   AHAZARD2(T)  exogenous hazard function 
   KUM_FUNC(T)  probability of dying definition ; 
 
H_D_FUNC(T).. H_D(T) =E= 0$(ORD(T) EQ 1) + (H(T) - H(T-1))$(ORD(T) GT 1); 
 
H_FUNC(T).. H(T) =E= H0$(ORD(T) EQ 1) + (EXP(-10*delta(T-1))*H(T-1) +  
(1/delta(T-1)*(1-EXP(-10*delta(T-1)))*(I(T-1)+0.00001)**gamma))$(ORD(T)GT 1); 
 
A_FUNC(T)..  A(T) =E= A0$(ORD(T) EQ 1) + (EXP(10*rate)*A(T-1) + 
(1/rate*(EXP(10*rate)-1)) * (Y(T-1) - q(T-1) * I(T-1) - p(T-1) * C(T-1)) )$ 
(ORD(T)GT 1) ;   
 
BUDGET(T)..  q(T) * I(T) + p(T) * C(T) - Y(T) =L= A(T) ;  
 
K_FUNC(T)$(not(betainf)).. K(T) =E= (H0/(1 + kbeta))$(ORD(T) EQ 1) + 
(K(T-1)/(1 + kbeta) + (kbeta/((1+kbeta)**2))*H0 + H_D(T))$(ORD(T) GT 1); 
 
K_FUNC2(T)$(betainf).. K(T) =E= H_D(T); 
 
AHAZARD(T)$(haz).. LY(T) =E= 0$(ORD(T) EQ 1)+(LY(T-1)+  
10 * PAR1*PAR2*(1/((H(T)/critical)**3+1))**(PAR2-1))$(ORD(T) GT 1) ; 
 
AHAZARD2(T)$(not(haz)).. LY(T) =E= 0$(ORD(T) EQ 1)+(LY(T-1)+  
10 * PAR1*PAR2*(1/((EX_H(T)/critical)**3+1))**(PAR2-1))$(ORD(T) GT 1) ; 
 





UTILITY.. UTIL =E= SUM(T, EXP(-LY(T))*EXP(-(10 * pref)*(ORD(T)-1))*((C(T) 
+ 100)**alpha + (K(T) + 100)**beta)); 
 
MODEL 
   HEALTH /ALL/; 
 
OPTION ITERLIM = 25000, RESLIM = 5000; 
HEALTH.OPTFILE = 1;  
 
   I.LO(T) = 0 ; 
   C.LO(T) = 0.0001 ; 
   A.LO(T) = 0 ; 
   H.LO(T) = 0.0001 ; 
   KUM.UP(T) = 1.0 ; 
   H_D.LO(T) = -99.9999 ; 
   H.UP(T) = 10000000; 
   K.LO(T) = -99.9999 ; 
 
* Use the hazard function 
 
  haz = 1; 
 
SOLVE HEALTH MAXIMIZING UTIL USING NLP ; 
 
lifetime1 = SUM(T$((ORD(T) Gt 1)$(ORD(T) le 15)),10*(ORD(T)-1)*(KUM.L(T)-
KUM.L(T-1)))/KUM.L("140"); 
 
lifetime2 = SUM(T$((ORD(T) Gt 1)$(ORD(T) le 12)),10*(ORD(T)-1)*(KUM.L(T)-
KUM.L(T-1)))/KUM.L("110"); 
 
Display lifetime1; 
Display lifetime2; 
 